Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma
Clinical trial NCT05536700 · UNKNOWN
Trial details
- NCT number
- NCT05536700
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-31
- Primary completion
- 2022-09-17
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.